Yahoo Finance

B. Braun Receives FDA Approval to Offer Broad Spectrum Intravenous Antibiotic-Meropenem, in Its Innovative DUPLEX(R) Container

BETHLEHEM, PA--(Marketwired - May 19, 2015) - B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced that it received U.S. Food and Drug Administration (FDA) ...
Yahoo Finance

B. Braun Launches Ready-to-Activate Cefazolin 3 Gram Pre-Mix in DUPLEX® Containers

BETHLEHEM, Pa., March 24, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced the launch of its new Cefazolin 3 g, the latest ...
Hosted on MSN

B. Braun Medical Introduces Cefazolin 3 g in DUPLEX Container

BETHLEHEM, PA — B. Braun Medical Inc. has expanded its DUPLEX® Container portfolio with the launch of Cefazolin 3 g, offering a new dosage option designed for surgical infection prevention in patients ...
PharmTech

B. Braun Medical Inc. Recalls Ceftazidime for Injection USP and Dextrose Injection USP (50 mL), Duplex Container

The company is recalling the product because of out-of-specification results for high molecular weight polymers. Braun Medical Inc. (B. Braun) is voluntarily recalling one lot of 2g Ceftazidime for ...
Pharmabiz

B. Braun introduces ready-to-activate Cefazolin 3 gram pre-mix in DUPLEX Containers

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced the launch of its new Cefazolin 3 g, the latest cefazolin dose addition to the DUPLEX Container ...